{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T10:52:57Z","timestamp":1769597577912,"version":"3.49.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1038\/s41401-019-0325-6","type":"journal-article","created":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T08:02:43Z","timestamp":1578902563000},"page":"661-669","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["A novel biphenyl compound IMB-S7 ameliorates hepatic fibrosis in BDL rats by suppressing Sp1-mediated integrin \u03b1v expression"],"prefix":"10.1038","volume":"41","author":[{"given":"Na","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang-shuang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-xuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-cheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong-guang","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju-xian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-wei","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,13]]},"reference":[{"key":"325_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1172\/JCI24282","volume":"115","author":"R Bataller","year":"2005","unstructured":"Bataller R, Brenner DA. Liver fibrosis. J Clin Investig. 2005;115:209\u201318.","journal-title":"J Clin Investig."},{"key":"325_CR2","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/S0140-6736(08)60383-9","volume":"371","author":"D Schuppan","year":"2008","unstructured":"Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. 2008;371:838\u201351.","journal-title":"Lancet"},{"key":"325_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000441229","volume":"97","author":"IH Hasan","year":"2016","unstructured":"Hasan IH, El-Desouky MA, Hozayen WG, Abd el Aziz GM. Protective effect of zingiber officinale against CCl4-induced liver fibrosis is mediated through downregulating the TGF-beta1\/Smad3 and NF-\u03baB\/I\u03baB pathways. Pharmacology. 2016;97:1\u20139.","journal-title":"Pharmacology"},{"key":"325_CR4","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1111\/1440-1681.12294","volume":"41","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Meng XM, Huang XR, Wang XJ, Yang L, Lan HY. Transforming growth factor-beta1 mediates psoriasis-like lesions via a Smad3-dependent mechanism in mice. Clin Exp Pharmacol Physiol. 2014;41:921\u201332.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"325_CR5","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S0092-8674(02)00971-6","volume":"110","author":"RO Hynes","year":"2002","unstructured":"Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell. 2002;110:673\u201387.","journal-title":"Cell"},{"key":"325_CR6","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nri3623","volume":"14","author":"A Pellicoro","year":"2014","unstructured":"Pellicoro A, Ramachandran P, Iredale JP, Fallowfield JA. Liver fibrosis and repair: immune regulation of wound healing in a solid organ. Nat Rev Immunol 2014;14:181\u201394.","journal-title":"Nat Rev Immunol"},{"key":"325_CR7","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0092-8674(00)80545-0","volume":"96","author":"JS Munger","year":"1999","unstructured":"Munger JS, Huang X, Kawakatsu H, Griffiths MJ, Dalton SL, Wu J, et al. The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell. 1999;96:319\u201328.","journal-title":"Cell"},{"key":"325_CR8","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1002\/hep.21849","volume":"46","author":"B Wang","year":"2007","unstructured":"Wang B, Dolinski BM, Kikuchi N, Leone DR, Peters MG, Weinreb PH, et al. Role of alphavbeta6 integrin in acute biliary fibrosis. Hepatology. 2007;46:1404\u201312.","journal-title":"Hepatology"},{"key":"325_CR9","doi-asserted-by":"publisher","first-page":"110","DOI":"10.2353\/ajpath.2007.060158","volume":"170","author":"K Hahm","year":"2007","unstructured":"Hahm K, Lukashev ME, Luo Y, Yang WJ, Dolinski BM, Weinreb PH, et al. Alphav beta6 integrin regulates renal fibrosis and inflammation in Alport mouse. Am J Pathol 2007;170:110\u201325.","journal-title":"Am J Pathol"},{"key":"325_CR10","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.jhep.2007.11.021","volume":"48","author":"Y Popov","year":"2008","unstructured":"Popov Y, Patsenker E, Stickel F, Zaks J, Bhaskar KR, Niedobitek G, et al. Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies. J Hepatol 2008;48:453\u201364.","journal-title":"J Hepatol"},{"key":"325_CR11","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s00441-016-2407-9","volume":"365","author":"KP Conroy","year":"2016","unstructured":"Conroy KP, Kitto LJ, Henderson NC. Alphav integrins: key regulators of tissue fibrosis. Cell Tissue Res. 2016;365:511\u20139.","journal-title":"Cell Tissue Res"},{"key":"325_CR12","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1038\/nm.3282","volume":"19","author":"NC Henderson","year":"2013","unstructured":"Henderson NC, Arnold TD, Katamura Y, Giacomini MM, Rodriguez JD, McCarty JH, et al. Targeting of alphav integrin identifies a core molecular pathway that regulates fibrosis in several organs. Nat Med 2013;19:1617\u201324.","journal-title":"Nat Med"},{"key":"325_CR13","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1083\/jcb.200704042","volume":"179","author":"PJ Wipff","year":"2007","unstructured":"Wipff PJ, Rifkin DB, Meister JJ, Hinz B. Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix. J Cell Biol 2007;179:1311\u201323.","journal-title":"J Cell Biol"},{"key":"325_CR14","first-page":"169","volume":"50","author":"SS Zhao","year":"2015","unstructured":"Zhao SS, Wang JX, Wang YC, Shao RG, He HW. [Establishment and application of a high-throughput drug screening model based on COL1A1 promoter for anti-liver fibrosis]. Yao Xue Xue Bao. 2015;50:169\u201373.","journal-title":"Yao Xue Xue Bao"},{"key":"325_CR15","first-page":"538","volume":"82","author":"S Cui","year":"2002","unstructured":"Cui S, Wang M, Fan G. Anti-HBV efficacy of bifendate in treatment of chronic hepatitis B, a primary study. Zhonghua Yi Xue Za Zhi. 2002;82:538\u201340.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"325_CR16","doi-asserted-by":"crossref","unstructured":"Wu T, Roger H, Xie L, Liu G, Hao B. Bicyclol for chronic hepatitis B. Cochrane Database Syst Rev 2006;4:CD004480.","DOI":"10.1002\/14651858.CD004480.pub2"},{"key":"325_CR17","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/nprot.2015.017","volume":"10","author":"I Mederacke","year":"2015","unstructured":"Mederacke I, Dapito DH, Affo S, Uchinami H, Schwabe RF. High-yield and high-purity isolation of hepatic stellate cells from normal and fibrotic mouse livers. Nat Protoc 2015;10:305\u201315.","journal-title":"Nat Protoc"},{"key":"325_CR18","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.1210\/endo.142.9.8380","volume":"142","author":"GE Walker","year":"2001","unstructured":"Walker GE, Wilson EM, Powell D, Oh Y. Butyrate, a histone deacetylase inhibitor, activates the human IGF binding protein-3 promoter in breast cancer cells: molecular mechanism involves an Sp1\/Sp3 multiprotein complex. Endocrinology. 2001;142:3817\u201327.","journal-title":"Endocrinology"},{"key":"325_CR19","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.jhep.2011.09.024","volume":"56","author":"EL Ellis","year":"2012","unstructured":"Ellis EL, Mann DA. Clinical evidence for the regression of liver fibrosis. J Hepatol 2012;56:1171\u201380.","journal-title":"J Hepatol"},{"key":"325_CR20","first-page":"300","volume":"38","author":"HA El-Beshbishy","year":"2005","unstructured":"El-Beshbishy HA. The effect of dimethyl dimethoxy biphenyl dicarboxylate (DDB) against tamoxifen-induced liver injury in rats: DDB use is curative or protective. J Biochem Mol Biol 2005;38:300\u20136.","journal-title":"J Biochem Mol Biol"},{"key":"325_CR21","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1034\/j.1600-0676.2000.020004319.x","volume":"20","author":"SG Kim","year":"2000","unstructured":"Kim SG, Kim HJ, Choi SH, Ryu JY. Inhibition of lipopolysaccharide-induced I-kappaB degradation and tumor necrosis factor-alpha expression by dimethyl-4,4\u2019-dimethoxy-5,6,5\u2019,6\u2019-dimethylene dioxybiphenyl-2,2\u2019-dicarboxylate (DDB): minor role in hepatic detoxifying enzyme expression. Liver. 2000;20:319\u201329.","journal-title":"Liver"},{"key":"325_CR22","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/nrd3810","volume":"11","author":"RJ Akhurst","year":"2012","unstructured":"Akhurst RJ, Hata A. Targeting the TGFbeta signalling pathway in disease. Nat Rev Drug Discov 2012;11:790\u2013811.","journal-title":"Nat Rev Drug Discov"},{"key":"325_CR23","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1002\/jcb.20928","volume":"98","author":"Y Kang","year":"2006","unstructured":"Kang Y. Pro-metastasis function of TGFbeta mediated by the Smad pathway. J Cell Biochem. 2006;98:1380\u201390.","journal-title":"J Cell Biochem"},{"key":"325_CR24","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nature10152","volume":"474","author":"M Shi","year":"2011","unstructured":"Shi M, Zhu J, Wang R, Chen X, Mi L, Walz T, et al. Latent TGF-beta structure and activation. Nature. 2011;474:343\u20139.","journal-title":"Nature"},{"key":"325_CR25","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1194\/jlr.M031450","volume":"54","author":"W Wu","year":"2013","unstructured":"Wu W, Dong YW, Shi PC, Yu M, Fu D, Zhang CY, et al. Regulation of integrin alphaV subunit expression by sulfatide in hepatocellular carcinoma cells. J Lipid Res 2013;54:936\u201352.","journal-title":"J Lipid Res"},{"key":"325_CR26","doi-asserted-by":"publisher","first-page":"5845","DOI":"10.1210\/en.2012-1626","volume":"153","author":"I Garcia-Ruiz","year":"2012","unstructured":"Garcia-Ruiz I, Gomez-Izquierdo E, Diaz-Sanjuan T, Grau M, Solis-Munoz P, Munoz-Yague T, et al. Sp1 and Sp3 transcription factors mediate leptin-induced collagen alpha1(I) gene expression in primary culture of male rat hepatic stellate cells. Endocrinology. 2012;153:5845\u201356.","journal-title":"Endocrinology"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41401-019-0325-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41401-019-0325-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41401-019-0325-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:02:32Z","timestamp":1684616552000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-019-0325-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,13]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["325"],"URL":"https:\/\/doi.org\/10.1038\/s41401-019-0325-6","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,13]]},"assertion":[{"value":"18 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}